Delandistrogene moxeparvovec, a gene therapy approved for the treatment of Duchenne muscular dystrophy (DMD), was found tolerable and showed signs of efficacy in a real-world cohort ...

The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted the company to pause dosing in another study.

Italfarmaco’s oral HDAC inhibitor givinostat has been approved in the US as a treatment for Duchenne muscular dystrophy (DMD), becoming the first non-steroidal option for patients with all ...

The heart is made mostly of muscle, which is why almost all people with Duchenne muscular dystrophy (DMD) — a genetic disease that causes progressive weakness and wasting in muscles throughout the ...

Delandistrogene moxeparvovec showed significant long-term stabilization or slowed progression in DMD patients over 3 and 5 years compared to external controls. Clinical trials demonstrated ...

The U.S. Food and Drug Administration (FDA) has accepted Capricor Therapeutics’ application seeking approval of deramiocel — a cell therapy developed by the biotech company to treat heart muscle ...

DENTAL TRAINING: Nova Southeastern College of Dental Medicine, DMD; Spear Education Faculty Club Member; American Academy of Cosmetic Dentistry; International Academy of Facial Esthetics Dr. Amanda ...

Duchenne muscular dystrophy causes progressive muscle degeneration and weakness, but physical exercise should still be part of a comprehensive treatment strategy. Duchenne muscular dystrophy (DMD ...

Singer Chappell Roan has shared her favorite ads for her latest single, “The Giver,” on social media. Designed by creative ...

Dr. Sophon Heng D.D.S. caters to those people who don’t have dental insurance. His clinic provides comprehensive dental care ...